NCT06068595

Brief Summary

The hypothesis of this study is that musculoskeletal point of care ultrasonography would support the GP's decision and ultimately improve patient management. The aim of this study is to evaluate, in the context of suspected musculoskeletal abnormality, the contribution of musculoskeletal point of care ultrasonography to the general practitioner's overall decision-making strategy, defined according to the following 5 axes: diagnosis (I), therapy (II), patient orientation (III), prescription of complementary examinations (IV) and follow-up (V).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Apr 2024Oct 2027

First Submitted

Initial submission to the registry

September 22, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 5, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

October 5, 2023

Status Verified

September 1, 2023

Enrollment Period

3 years

First QC Date

September 22, 2023

Last Update Submit

September 28, 2023

Conditions

Keywords

musculoskeletal anomalyultrasonographygeneral practitioners

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients

    Percentage of patients for whom the musculoskeletal point of care ultrasonography led to a change in the GP's overall decision-making strategy (binary yes/no variable) of patients for whom led to a change in the GP's overall decision-making strategy (binary yes/no variable)

    3 years

Secondary Outcomes (12)

  • Frequency of the anatomical sites

    3 years

  • Frequency of modifications

    3 years

  • Frequency of diagnoses of post-CTA confirmation

    3 years

  • Frequency of diagnoses of post-CTA modifications

    3 years

  • Frequency of incidental diagnoses discovered at CTA

    3 years

  • +7 more secondary outcomes

Study Arms (1)

Patients

OTHER

Patient with musculoskeletal anomalies

Other: musculoskeletal ultrasound

Interventions

After clinical examination and medical interrogation, The investigating physician gives her decisions in the e-CRF according to the 5 axes: diagnosis (I), therapy (II), patient referral (III), prescription of additional tests (IV) and follow-up (V). The investigator performs the targeted musculoskeletal ultrasound with his personal ultrasound machine, following his usual operating procedure and give/keep the final diagnostic.

Patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Person who has received full information on the organization of the research and has given his/her consent
  • Be over 18 years of age
  • Present a symptomatology leading to suspicion of musculoskeletal pathology
  • Be able to give consent
  • Be affiliated to a social security scheme or benefit from such a scheme

You may not qualify if:

  • Chronic inflammatory rheumatism (rheumatoid arthritis, spondylitis, psoriatic arthritis, rheumatoid pseudo-polyarthritis, juvenile idiopathic arthritis, lupus, etc.).
  • Subjects benefiting from a legal protection measure (guardianship, curatorship, safeguard of justice).
  • Persons deprived of their liberty by judicial or administrative decision, persons under psychiatric care under articles L3212-1 and L3213-1.
  • Pregnant women
  • Nursing mothers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Hospital

Nancy, Vandoeuvre Lès Nancy, 54500, France

Location

Related Publications (5)

  • Sorensen B, Hunskaar S. Point-of-care ultrasound in primary care: a systematic review of generalist performed point-of-care ultrasound in unselected populations. Ultrasound J. 2019 Nov 19;11(1):31. doi: 10.1186/s13089-019-0145-4.

    PMID: 31749019BACKGROUND
  • Meyer R, Lin C, Yenokyan G, Ellen M. Diagnostic Utility of Ultrasound Versus Physical Examination in Assessing Knee Effusions: A Systematic Review and Meta-analysis. J Ultrasound Med. 2022 Jan;41(1):17-31. doi: 10.1002/jum.15676. Epub 2021 Mar 5.

    PMID: 33675099BACKGROUND
  • Nazarian LN. The top 10 reasons musculoskeletal sonography is an important complementary or alternative technique to MRI. AJR Am J Roentgenol. 2008 Jun;190(6):1621-6. doi: 10.2214/AJR.07.3385.

    PMID: 18492916BACKGROUND
  • Narula J, Chandrashekhar Y, Braunwald E. Time to Add a Fifth Pillar to Bedside Physical Examination: Inspection, Palpation, Percussion, Auscultation, and Insonation. JAMA Cardiol. 2018 Apr 1;3(4):346-350. doi: 10.1001/jamacardio.2018.0001.

    PMID: 29490335BACKGROUND
  • Andersen CA, Davidsen AS, Brodersen J, Graumann O, Jensen MB. Danish general practitioners have found their own way of using point-of-care ultrasonography in primary care: a qualitative study. BMC Fam Pract. 2019 Jun 28;20(1):89. doi: 10.1186/s12875-019-0984-x.

    PMID: 31253102BACKGROUND

MeSH Terms

Conditions

Musculoskeletal Abnormalities

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Boris Gass, Pr

    Central Hospital, Nancy, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 22, 2023

First Posted

October 5, 2023

Study Start

April 1, 2024

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

October 5, 2023

Record last verified: 2023-09

Locations